Gynesonics, now a part of Hologic

Gynesonics, now part of Hologic, is a medical device company focused on minimally invasive solutions for women’s health. The company specializes in the treatment of symptomatic uterine fibroids and heavy menstrual bleeding. Its flagship product, the Sonata® System, is the first FDA-cleared device that combines real-time intrauterine ultrasound imaging with targeted radiofrequency ablation in a transcervical, incisionless procedure. This innovative technology allows for both diagnostic imaging and treatment of uterine fibroids without incisions, providing a safer alternative to traditional surgical methods. The Sonata System empowers gynecologic surgeons by offering a precise treatment option that addresses conditions affecting women's quality of life. With its integration of ultrasound guidance, the system ensures accurate targeting of fibroids while preserving the uterus. Gynesonics primarily serves gynecologic surgeons and healthcare providers who are looking for effective, minimally invasive treatment options for their patients. Following its acquisition by Hologic, Gynesonics continues to enhance access to innovative fibroid treatments globally, contributing to Hologic’s commitment to advancing women’s health.

• Employees 92
• Founded 2005
• Annual Revenue $4030000000
• Total Funding $210491000